Acta Biomaterialia is an international journal that publishes peer-reviewed original research reports, review papers and communications in the broadly defined field of biomaterials science. The emphasis of the journal is on the relationship between biomaterial structure and function at all length scales.The scope of Acta Biomaterialia includes:Hypothesis-driven design of biomaterialsBiomaterial surface science linking structure to biocompatibility, including protein adsorption and cellular interactionsBiomaterial mechanical characterization and modeling at all scalesMolecular, statistical and other types of modeling applied to capture biomaterial behaviorInteractions of biological species with defined surfacesCombinatorial approaches to biomaterial developmentStructural biology as it relates structure to function for biologically derived materials that have application as a medical material, or as it aids in understanding the biological response to biomaterialsMethods for biomaterial characterizationProcessing of biomaterials to achieve specific functionalityMaterials development for arrayed genomic and proteomic screening
Advanced Bionics (ABS) is an international peer-reviewed, open access journal that publishes original research papers, reviews, letters, editorials, highlights, perspectives, comments and news.ABS focuses on the study of novel principles and functions observed in biological systems, as well as the application of this knowledge to address real-world scientific challenges.ABS aims to lead advancements in fundamental bionic research, pushing the boundaries of novel bionic investigations and fostering disruptive technologies within the field. Submissions to the journal are expected to provide fresh insights, possess scientific impact and a high level of quality, as well as contribute to shaping the future of bionic research.As an interdisciplinary journal, ABS covers a wide array of topics, including but not limited to:(1) Bionic Robotics, Electronics, and Intelligent Devices (2) Bio-inspired Artificial Intelligence (3) Biomechanics and Bionic Healthcare Engineering (4) Bio-inspired Functional Surfaces/Interfaces (5) Bio-inspired Functional Materials and Biosensors (6) Bio-inspired Energy System (7) Bio-manufacturing and Bionic Manufacturing (8) Bio-inspired structures and designEditorial Board
Advanced Orthopaedics focuses on advancing orthopedic science and clinical practice by publishing research that explores new ideas, questions conventional viewpoints, and highlighting studies that may challenge established theories and methods. The journal’s scope includes clinical studies introducing new perspectives and technologies, foundational research investigating new biological markers and mechanisms, and the evaluation of biomaterials aimed at enhancing tissue regeneration and repair.Advanced Orthopaedics publishes research across the full spectrum of orthopedic science, from fundamental inquiries to clinical applications and innovative material sciences. By broadening our scope to include these key areas, Advanced Orthopaedics serves as a platform for sharing impactful research and advancing material science that shapes the future of orthopedic treatments. We emphasize the importance of both positive and negative findings to contribute rigorous evidence to the field of orthopedic research.Topics covered include, but are not limited to:Clinical Orthopedic ResearchSurgical Innovations and OutcomesBiomechanics and Bone HealthOrthopedic PathologyBone Regeneration and RepairExperimental Biomaterials ApplicationNanotechnology in OrthopedicsTissue Engineering and Intelligent MaterialsBiocompatibility and Safety of Materials
Annals of 3D Printed Medicine examines the fast moving 3D printing innovation in the inter-disciplinary medical and biomedical research area.Also widely known by other terms such as additive manufacturing (AM) or rapid prototyping (RP), 3D printing engineering offers in Health and Medical Sciences - as an efficient and customizable manufacturing option - a great opportunity to reduce costs, time, trauma and healing periods:for healthcare professionals and drug and medical device companies to develop tailor-made (and often urgent) new solutions, services and concrete applications,for patients making care affordable, accessible and personalized,with the support of policies and under the pressure of growing expectations and demands.By giving high priority review and early publication to international peer-reviewed research and applications original works, Annals of 3D Printed Medicine is the home to collect innovative use of 3D-printing related technologies in the following medical and clinical situations: preoperative planning, instrumentalization and implantology, state modelling, medical education, storage, patient education, medico-legal, bioprinting, therapeutics.Annals of 3D Printed Medicine publishes:(guest) EditorialsResearch papersReviewsShort surveysTechnical notesShort communicationsLetters to the EditorThe journal endorses the FAIR Guiding Principles to support improved Findability, Accessibility, Interoperability and Reuse - and follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), as well as the Code of conduct for editors issued by the Committee on Publication Ethics (COPE).Annals of 3D Printed Medicine is a Gold Open Access e-only journal and is available on ScienceDirect.
Bioactive Materials is an international, peer-reviewed research publication covering all aspects of bioactive materials. The journal welcomes the submission of research papers, reviews and rapid communications that are concerned with the science and engineering of next-generation biomaterials that come into contact with cells, tissues or organs across all living species. Bioactive materials will feature adaptiveness to the biological environment, being designed to stimulate and/or direct appropriate cellular and tissue responses, or control interactions with microbiological species.The journal publishes research on the entire range of bioactive materials that have been specifically and functionally engineered or designed in term of either their physical form (e.g. particulate, fibre, etc.), topology (e.g. porosity, surface roughness, etc.) or dimensions (i.e. macro to nano-scales). The journal invites contributions from the following categories of bioactive materials : (i) bioactive metals and alloys, (ii) bioactive inorganics: ceramics, glasses and carbon-based materials, (iii) bioactive polymers and gels, (iv) bioactive materials sourced from nature and (v) bioactive composites, for use in human or veterinary medicine as implants, tissue engineering scaffolds, cell/drug/gene carriers, imaging and sensing devices.Peer review This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review. Peer review under the responsibility of KeAi Communications Co., Ltd.Editorial Board
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!
Formerly known as Materials Science and Engineering: C, with a 2022 IF of 7.9.Biomaterials Advances includes topics at the interface of the biomedical sciences and materials engineering. These topics include: Bioinspired and biomimetic materials for medical applicationsMaterials of biological origin for medical applicationsMaterials for "active" medical applicationsSelf-assembling and self-healing materials for medical applications"Smart" (i.e., stimulus-response) materials for medical applicationsCeramic, metallic, polymeric, and composite materials for medical applicationsMaterials for in vivo sensingMaterials for in vivo imagingMaterials for delivery of pharmacologic agents and vaccinesNovel approaches for characterizing and modeling materials for medical applicationsManuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Biomaterials Advances. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!
Formerly known as Materials Science and Engineering: C, with a 2022 IF of 7.9.Biomaterials Advances includes topics at the interface of the biomedical sciences and materials engineering. These topics include: Bioinspired and biomimetic materials for medical applicationsMaterials of biological origin for medical applicationsMaterials for "active" medical applicationsSelf-assembling and self-healing materials for medical applications"Smart" (i.e., stimulus-response) materials for medical applicationsCeramic, metallic, polymeric, and composite materials for medical applicationsMaterials for in vivo sensingMaterials for in vivo imagingMaterials for delivery of pharmacologic agents and vaccinesNovel approaches for characterizing and modeling materials for medical applicationsManuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Biomaterials Advances. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!
Biomaterials and Biosystems is the newest title in Elsevier's biomaterials science portfolio; it sits alongside Biomaterials, Materials Today Bio and Biomaterials Advances . As part of the broader Materials Today family, Biomaterials and Biosystems offers authors rigorous peer review, rapid decisions, and high visibility.Biomaterials and Biosystems is an interdisciplinary open access journal that publishes work at the nexus of engineering, chemistry, biology and medicine. The Journal covers the full spectrum of research, technology development and clinical translation of the biomedical engineering discipline. The Journal will effectively disseminate new knowledge, technologies, tools and discoveries in the field of human health and/or healthcare to the scientific community and to the wider community. The Journal commits to adhere to strict confidentiality agreements and affirms commitment to integrity and ethical conduct of the highest standard.Biomaterials and Biosystems selectively publishes manuscripts that:Deal with the development, assessment and application of the next generation of functional implantable devices that aspire to treat, augment or replace diseased and / or injured tissues, organs or functions of the body with their therapeutic capacity;Develop, assess and prove function of the next generation of biological systems that enable disease prevention, diagnosis, progression, monitoring, mitigation and treatment; andDiscuss ethical and social implications of educational, scientific, technological and clinical developments in the applied field of biomedical engineering.Indicative example of specific topics covered by Biomaterials and Biosystems include: Advanced Therapy Medicinal Products; Artificial Organs; Bioadhesives; Bioceramics; Bioelectronics; Bioengineering; Biofabrication; Biomechanics; Biomedical Engineering; Bionics; Biopolymers; Biosensors; Biotechnology; Cardiovascular Engineering; Cell Delivery; Cell Engineering; Clinical Trials; Developmental Engineering; Diagnostics; Differentiated Cells; Drug Delivery; Extracellular Matrix; Functionalised Biomaterials; Gene Delivery; Growth Factor Delivery; Hard Tissue Engineering; Hybrid Biomaterials; Imaging; Implants; Immune Response; Immunoengineering; In vitro models; In vivo models; Interfaces; Lab-on-Chip; Mechanobiology; Medical Devices; Modular Biomaterials; Molecular Engineering; Nanobiomaterials; Nanomedicine; Neural Engineering; Ophthalmic; Organ-on-Chip; Orthopaedics; Pluripotent Stem Cells; Regenerative Medicine; Self-assembly; Skeletal Engineering; Soft Tissue Engineering; Stem Cells; Synthetic Biology; Synthetic Polymers; Systems Biology; Tissue Engineering; Translational Medicine; Vaccines; Wound HealingBiomaterials and Biosystems accepts the following types of manuscripts:Research Communication: A hypothesis driven manuscript with at least detailed in vitro biological analysis and a maximum of 5 main display items (figures and tables). Additional display items (no limit) can be provided as supplementary information.Research Note: A hypothesis driven manuscript with at least detailed in vitro biological analysis and a maximum of 3 main display items (figures and tables). Additional display items (no limit) can be provided as supplementary information.Progress Report: An authoritative mini review (no more than 6,000 words, including tables, acknowledgements, references, etc.) with a maximum of 4 display items (figures and tables), which will provide a critical view / perspective of the subject in hand of the last 10 years. Authors should clearly demonstrate in their cover letter their relevant expertise in the topic of the manuscript.Review: An authoritative and educational in nature review (no more than 12,000 words, including tables, acknowledgements, references, etc.) with a maximum of 8 display items (figures and tables), which will provide a comprehensive literature review of the subject in hand. Authors should clearly demonstrate in their cover letter their relevant expertise in the topic of the manuscript.Leading Opinion: Invited opinionated papers about established and emerging research topics, as well as relevant ethical, legal and societal issues. Leading Opinion manuscripts have strict limit of 2 authors, 100 words abstract, 1,500 words main text, 1 level headings, 10 references and 1 elegant and descriptive figure.We look forward to receiving your submissions!
An International Journal Devoted to Fundamental and Applied Research on Colloid and Interfacial Phenomena in Relation to Systems of Biological OriginColloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.